Perioperative NALIRIFOX (liposomal Irinotecan in Combination with Fluorouracil, Leucovorin, and Oxaliplatin) in Resectable Pancreatic Adenocarcinoma: Randomized Phase II Trial

NCT06816914 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
84
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Taichung Veterans General Hospital

Collaborators